Poly (ADP-ribose) polymerase inhibition: past, present and future

NJ Curtin, C Szabo - Nature Reviews Drug Discovery, 2020 - nature.com
The process of poly (ADP-ribosyl) ation and the major enzyme that catalyses this reaction,
poly (ADP-ribose) polymerase 1 (PARP1), were discovered more than 50 years ago. Since …

Regulated necrosis: disease relevance and therapeutic opportunities

M Conrad, JPF Angeli, P Vandenabeele… - Nature reviews Drug …, 2016 - nature.com
The discovery of regulated cell death presents tantalizing possibilities for gaining control
over the life–death decisions made by cells in disease. Although apoptosis has been the …

Nitric oxide and peroxynitrite in health and disease

P Pacher, JS Beckman, L Liaudet - Physiological reviews, 2007 - journals.physiology.org
The discovery that mammalian cells have the ability to synthesize the free radical nitric oxide
(NO) has stimulated an extraordinary impetus for scientific research in all the fields of …

The therapeutic potential of poly (ADP-ribose) polymerase inhibitors

L Virag, C Szabó - Pharmacological reviews, 2002 - ASPET
Poly (ADP-ribose) polymerase-1 (PARP-1) is a member of the PARP enzyme family
consisting of PARP-1 and several recently identified novel poly (ADP-ribosylating) enzymes …

Therapeutic applications of PARP inhibitors: anticancer therapy and beyond

NJ Curtin, C Szabo - Molecular aspects of medicine, 2013 - Elsevier
The aim of this article is to describe the current and potential clinical translation of
pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …

Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

X Du, T Matsumura, D Edelstein… - The Journal of …, 2003 - Am Soc Clin Investig
In this report, we show that hyperglycemia-induced overproduction of superoxide by the
mitochondrial electron transport chain activates the three major pathways of hyperglycemic …

Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors

P Jagtap, C Szabó - Nature reviews Drug discovery, 2005 - nature.com
Abstract Poly (ADP-ribose) polymerases (PARPs) are involved in the regulation of many
cellular functions. Three consequences of the activation of PARP1, which is the main isoform …

Evolution of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic

DV Ferraris - Journal of medicinal chemistry, 2010 - ACS Publications
Poly (ADP-ribose) polymerase-1 (PARP-1a) has been an actively pursued drug discovery
target for almost 3 decades. Often referred to as the “guardian angel of DNA”, 1 this …

[HTML][HTML] Role of quorum sensing in bacterial infections

I Castillo-Juárez, T Maeda… - World Journal of …, 2015 - ncbi.nlm.nih.gov
Quorum sensing (QS) is cell communication that is widely used by bacterial pathogens to
coordinate the expression of several collective traits, including the production of multiple …

Role of poly (ADP‐ribose) polymerase 1 (PARP‐1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

P Pacher, C Szabó - Cardiovascular drug reviews, 2007 - Wiley Online Library
Accumulating evidence suggests that the reactive oxygen and nitrogen species are
generated in cardiomyocytes and endothelial cells during myocardial ischemia/reperfusion …